合富醫療控股股份有限公司
該股 RSI(6) 為 16.3，處於超賣區間，短線跌深可能有反彈機會。股價跌破5日、20日、60日、120日均線。短中期均線呈空頭排列，趨勢偏空。KD 指標偏低（K=18.8），有反彈空間；MACD 柱狀體為負值，空方動能持續。 （自動產生 · 非投資建議）
合富醫療控股股份有限公司（Cowealth Medical Holding Co., Ltd.）及其子公司在台、中、港貿易醫療設備與試劑。提供「acme」賦能計畫，包含 AI 輔助臨床決策系統。產品涵蓋電腦斷層放射手術系統（CyberKnife）、乾眼症診斷治療系統（Lipiview）及 MRI 導引放療系統。公司成立於 1997 年，總部位於開曼群島。
| 日期 | 外資 | 投信 | 自營商 | 合計 |
|---|---|---|---|---|
| 11-10 | 0 | 0 | 0 | 0 |
| 11-09 | +12 | 0 | 0 | +12 |
| 11-06 | -7 | 0 | 0 | -7 |
| 11-05 | -19 | 0 | 0 | -19 |
| 11-04 | -11 | 0 | 0 | -11 |
| 11-03 | -12 | 0 | 0 | -12 |
| 11-02 | -9 | 0 | 0 | -9 |
| 10-30 | 0 | 0 | 0 | 0 |
| 10-29 | -6 | 0 | 0 | -6 |
| 10-28 | -4 | 0 | 0 | -4 |
| 10-27 | -2 | 0 | 0 | -2 |
| 10-22 | -10 | 0 | 0 | -10 |
| 10-21 | -3 | 0 | 0 | -3 |
| 10-20 | -2 | 0 | 0 | -2 |
| 10-19 | -3 | 0 | 0 | -3 |
| 10-16 | +1 | 0 | 0 | +1 |
| 10-15 | -5 | 0 | 0 | -5 |
| 10-14 | -5 | 0 | 0 | -5 |
| 10-13 | -7 | 0 | 0 | -7 |
| 10-12 | -4 | 0 | 0 | -4 |
| 10-08 | -1 | 0 | 0 | -1 |
| 10-07 | -2 | 0 | 0 | -2 |
| 10-06 | -1 | 0 | -1 | -2 |
| 10-05 | -7 | 0 | 0 | -7 |
| 10-02 | -3 | 0 | 0 | -3 |
| 10-01 | 0 | 0 | 0 | 0 |
| 09-30 | -3 | 0 | 0 | -3 |
| 09-29 | +18 | 0 | 0 | +18 |
| 09-24 | +2 | 0 | 0 | +2 |
| 09-23 | +4 | 0 | +1 | +5 |
| 09-22 | +5 | 0 | 0 | +5 |
| 09-21 | -3 | 0 | 0 | -3 |
| 09-18 | -2 | 0 | 0 | -2 |
| 09-17 | -1 | 0 | 0 | -1 |
| 09-16 | -3 | 0 | 0 | -3 |
| 09-15 | -6 | 0 | 0 | -6 |
| 09-14 | +1 | 0 | 0 | +1 |
| 09-11 | -1 | 0 | 0 | -1 |
| 09-10 | -5 | 0 | 0 | -5 |
| 09-09 | +1 | 0 | 0 | +1 |
| 09-08 | -8 | 0 | 0 | -8 |
| 09-07 | +3 | 0 | 0 | +3 |
| 09-04 | 0 | 0 | 0 | 0 |
| 09-03 | 0 | 0 | 0 | 0 |
| 09-02 | +1 | 0 | +1 | +2 |
| 09-01 | 0 | 0 | 0 | 0 |
| 08-31 | +1 | 0 | 0 | +1 |
| 08-28 | +4 | 0 | 0 | +4 |
| 08-27 | 0 | 0 | 0 | 0 |
| 08-26 | 0 | 0 | 0 | 0 |
| 08-25 | -12 | 0 | -1 | -13 |
| 08-24 | -6 | 0 | +1 | -5 |
| 08-21 | -1 | 0 | 0 | -1 |
| 08-20 | -2 | 0 | 0 | -2 |
| 08-19 | -11 | 0 | -1 | -12 |
| 08-18 | +1 | 0 | +1 | +2 |
| 08-17 | -2 | 0 | 0 | -2 |
| 08-14 | +2 | 0 | 0 | +2 |
| 08-13 | -1 | 0 | 0 | -1 |
| 08-12 | +4 | 0 | 0 | +4 |
| 08-11 | +4 | 0 | +1 | +5 |
| 08-10 | +4 | 0 | 0 | +4 |
| 08-07 | -2 | 0 | 0 | -2 |
| 08-06 | +3 | 0 | 0 | +3 |
| 08-05 | -4 | 0 | 0 | -4 |
| 08-04 | +17 | 0 | 0 | +17 |
| 08-03 | +58 | 0 | 0 | +58 |
| 07-31 | +115 | 0 | 0 | +115 |
| 07-30 | +102 | 0 | 0 | +102 |
| 07-29 | +129 | 0 | 0 | +129 |
| 07-28 | +66 | 0 | 0 | +66 |
| 07-27 | +10 | 0 | +1 | +11 |
| 07-24 | +6 | 0 | 0 | +6 |
| 07-23 | +14 | 0 | 0 | +14 |
| 07-22 | +3 | 0 | 0 | +3 |
| 07-21 | 0 | 0 | 0 | 0 |
| 07-20 | +44 | 0 | 0 | +44 |
| 07-17 | +5 | 0 | +1 | +6 |
| 07-16 | +9 | 0 | 0 | +9 |
| 07-15 | +14 | 0 | 0 | +14 |
| 07-14 | -2 | 0 | 0 | -2 |
| 07-13 | +4 | 0 | 0 | +4 |
| 07-09 | +7 | 0 | 0 | +7 |
| 07-08 | +25 | 0 | 0 | +25 |
| 07-07 | +15 | 0 | 0 | +15 |
| 07-06 | -7 | 0 | 0 | -7 |
| 07-03 | +9 | 0 | 0 | +9 |
| 07-02 | +5 | 0 | 0 | +5 |
| 07-01 | +29 | 0 | +1 | +30 |
| 06-30 | +8 | 0 | 0 | +8 |
| 06-29 | +9 | 0 | 0 | +9 |
| 06-26 | -8 | 0 | 0 | -8 |
| 06-25 | +5 | 0 | 0 | +5 |
| 06-24 | +15 | 0 | 0 | +15 |
| 06-23 | +11 | 0 | 0 | +11 |
| 06-22 | -19 | 0 | 0 | -19 |
| 06-18 | -13 | 0 | 0 | -13 |
| 06-17 | +21 | 0 | 0 | +21 |
| 06-16 | -27 | 0 | 0 | -27 |
| 06-15 | -16 | 0 | 0 | -16 |
| 06-12 | -62 | 0 | 0 | -62 |
| 06-11 | -235 | 0 | 0 | -235 |
| 06-10 | -159 | 0 | 0 | -159 |
| 06-09 | -233 | 0 | 0 | -233 |
| 06-08 | +331 | 0 | 0 | +331 |
| 06-05 | +97 | 0 | 0 | +97 |
| 06-04 | +5 | 0 | 0 | +5 |
| 06-03 | +3 | 0 | 0 | +3 |
| 06-02 | +40 | 0 | 0 | +40 |
| 06-01 | +45 | 0 | 0 | +45 |
| 05-29 | -4 | 0 | 0 | -4 |
| 月份 | 營收 | MoM% | YoY% |
|---|---|---|---|
| 2026/10 | 1.84 億 | -46.9% | +12.5% |
| 2026/09 | 3.46 億 | +52.7% | +27.4% |
| 2026/08 | 2.26 億 | -7.8% | -13.2% |
| 2026/07 | 2.46 億 | -28.6% | +2.6% |
| 2026/06 | 3.44 億 | +54.5% | +39.6% |
| 2026/05 | 2.23 億 | -22.6% | -10.9% |
| 2026/04 | 2.87 億 | +11.3% | -10.9% |
| 2026/03 | 2.58 億 | +25.6% | -14.3% |
| 2026/02 | 2.06 億 | -13.6% | -9.7% |
| 2026/01 | 2.38 億 | -12.2% | -10.2% |
| 2025/12 | 2.71 億 | +46.9% | -32.9% |
| 2025/11 | 1.85 億 | - | -47.3% |